Ching Yau Yi
Comptroller/Controller/Auditor at CHEMOCENTRYX, INC.
Ching Yau Yi active positions
Companies | Position | Start | End |
---|---|---|---|
CHEMOCENTRYX, INC. | Comptroller/Controller/Auditor | 06/06/2022 | - |
Career history of Ching Yau Yi
Former positions of Ching Yau Yi
Companies | Position | Start | End |
---|---|---|---|
BRIDGEBIO PHARMA, INC. | Comptroller/Controller/Auditor | 07/10/2019 | 01/03/2022 |
NEKTAR THERAPEUTICS | Director of Finance/CFO | 01/05/2018 | 01/10/2019 |
THERAVANCE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2013 | 01/05/2018 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/2003 | 01/11/2013 |
Training of Ching Yau Yi
Nanyang Technological University | Undergraduate Degree |
Statistics
International
United States | 5 |
Singapore | 2 |
China | 2 |
Operational
Comptroller/Controller/Auditor | 3 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
BRIDGEBIO PHARMA, INC. | Health Technology |
NEKTAR THERAPEUTICS | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
Private companies | 2 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Ching Yau Yi
- Experience